Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMAG

AMAG Pharmaceuticals (AMAG) Stock Price, News & Analysis

AMAG Pharmaceuticals logo

About AMAG Pharmaceuticals Stock (NASDAQ:AMAG)

Advanced Chart

Key Stats

Today's Range
$13.75
$13.75
50-Day Range
$13.69
$13.75
52-Week Range
$4.41
$13.80
Volume
N/A
Average Volume
950,664 shs
Market Capitalization
$477.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMAG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMAG Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMAG Stock News Headlines

AMAG Pharmaceuticals, Inc. (AMU.DE)
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer
KalVista Appoints Brian Piekos as Chief Financial Officer
See More Headlines

AMAG Stock Analysis - Frequently Asked Questions

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) issued its earnings results on Monday, May, 11th. The specialty pharmaceutical company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $0.27. The specialty pharmaceutical company earned $68.66 million during the quarter, compared to analysts' expectations of $64.95 million. AMAG Pharmaceuticals had a negative trailing twelve-month return on equity of 16.92% and a negative net margin of 74.93%.

Based on aggregate information from My MarketBeat watchlists, some other companies that AMAG Pharmaceuticals investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Meta Platforms (META), Bausch Health Cos (BHC), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
5/11/2020
Today
8/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:AMAG
CIK
792977
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$466.46 million
Net Margins
-74.93%
Pretax Margin
N/A
Return on Equity
-16.92%
Return on Assets
-5.96%

Debt

Debt-to-Equity Ratio
1.13
Current Ratio
1.75
Quick Ratio
1.45

Sales & Book Value

Annual Sales
$327.75 million
Price / Sales
1.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.37 per share
Price / Book
1.87

Miscellaneous

Outstanding Shares
34,725,000
Free Float
N/A
Market Cap
$477.47 million
Optionable
Optionable
Beta
0.89
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:AMAG) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners